KUMAR, A. H. Network Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy. Biology, Engineering, Medicine and Science Reports, [S. l.], v. 7, n. 2, p. 21–24, 2021. DOI: 10.5530/bems.7.2.8. Disponível em: https://bemsreports.org/index.php/bems/article/view/116. Acesso em: 3 dec. 2021.